Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPB or TPVB Versus Intravenous Fentanyl for On-pump CABG Surgery
NCT07911943Phase 1Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Jan 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bupivacaine in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoints: Duration of analgesia up to 12 hours, Visual Analogue Pain Score up to 12 hours and 1 more. Started Jan 2026; status: active, not recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07911943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911943.